NIH Data Suggest Brain Glucose Metabolism Is Linked to Alzheimer Pathogenesis
May 22nd 2020The data included more than 2000 brains and approximately 400 cerebrospinal fluid samples, and showed that a protein network module linked to glucose metabolism was also elevated in cerebrospinal fluid in early stages of the disease.
Second Dose of Ubrogepant Is Safe and Effective in Acute Migraine
May 22nd 2020The study author, director of MedStar Georgetown Headache Center, and associate professor of neurology at MedStar Georgetown University Hospital discussed the findings of a pooled analysis of the ACHIEVE I and II studies of ubrogepant.
Andrew Blumenfeld, MD: Long-Term OnabotulimuntoxinA Use in the COMPEL Study
May 20th 2020The director of the Headache Center of Southern California discussed the findings of the study, as well as what these data might suggest about how onabotulinumtoxinA fits into the shifting landscape of chronic migraine care.
Plasma P-Tau181 Biomarker May Be Accessible, Scalable Test for Alzheimer Disease
May 20th 2020Findings from an analysis of a large population of individuals suggest that the blood immunoassay can predict tau and amyloid-ß pathologies, as well as differentiate and identify Alzheimer disease across the clinical spectrum.
Amy Sullivan, PsyD, ABPP: Interdisciplinary Care in MS
May 20th 2020The director of behavioral medicine at the Mellen Center for MS Treatment and Research at Cleveland Clinic discussed the importance of interdisciplinary care and ways it can be incorporated for patients with multiple sclerosis.